Meridian Bioscience Inc.

Meridian Bioscience Inc.

VIVO

Get informed when a big investor buys or sells

+ Follow
Market Cap$68.17M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Meridian Bioscience Inc.Meridian Bioscience Inc.4.2--1%-0.1
$35.10

Current Fair Value

802.3% upside

Undervalued by 802.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$68.17 Million
Enterprise Value$26.32 Million
Dividend Yield$- (-)
Earnings per Share$-
Beta-0.69
Outstanding Shares-

Return

Return on Equity-0.79%ROE
Return on Assets-0.59%
Return on Invested Capital6.90%

Valuation & Multiples

P/E Ratio4.21P/E Ratio
PEG-1.43PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue0.09
Enterprise Value to EBIT1.01
Enterprise Value to Net Income-10
Total Debt to Enterprise1.23
Debt to Equity0.09Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
September 4, 2026
EPS Estimate
-
Average shareholder expectation
Revenue Estimate
-
Average shareholder expectation

Next Earnings Call

Expected Date
February 12, 2027
EPS Estimate
-
Average shareholder expectation
Revenue Estimate
-
Average shareholder expectation

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About Meridian Bioscience Inc.

CEO: John Kenny